Vandack Nobre Selected Research

Procalcitonin

1/2020	Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: a patient-level meta-analysis from randomized controlled trials.
1/2018	Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials.
1/2018	Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials.
1/2018	Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis.
12/2017	Management of Respiratory Infections with Use of Procalcitonin: Moving toward More Personalized Antibiotic Treatment Decisions.
10/2017	Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
6/2016	Prognostic value of procalcitonin in hospitalized patients with lower respiratory tract infections.
6/2016	Procalcitonin-guided protocol is not useful to manage antibiotic therapy in febrile neutropenia: a randomized controlled trial.
10/2015	Procalcitonin levels in schizophrenic patients and patients with sepsis.
9/2015	Prognostication of Mortality in Critically Ill Patients With Severe Infections.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vandack Nobre Research Topics

Disease

16	Infections 01/2022 - 03/2008
12	Sepsis (Septicemia) 01/2018 - 01/2007
11	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018 - 09/2012
9	Critical Illness (Critically Ill) 09/2020 - 03/2008
4	Bacteremia 01/2019 - 01/2007
4	Pneumonia (Pneumonitis) 05/2018 - 01/2012
4	Bacterial Infections (Bacterial Infection) 12/2017 - 09/2012
2	COVID-19 01/2022 - 08/2021
2	Acute Kidney Injury (Acute Renal Failure) 09/2020 - 01/2019
2	Neoplasms (Cancer) 01/2020 - 09/2019
2	Hemorrhage 01/2018 - 05/2013
2	Febrile Neutropenia 06/2016 - 01/2011
2	Fever (Fevers) 06/2016 - 01/2011
2	Septic Shock (Toxic Shock Syndrome) 03/2008 - 10/2007
1	Leukemia 06/2021
1	Low Cardiac Output 04/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2020
1	Leishmaniasis 12/2019
1	Communicable Diseases (Infectious Diseases) 09/2019
1	Toxemia 09/2019
1	Paralysis (Palsy) 09/2019
1	Botulism 09/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Delirium 01/2018
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2018
1	Urinary Tract Infections (Urinary Tract Infection) 01/2018
1	Chronic Bronchitis 01/2018
1	Heart Diseases (Heart Disease) 01/2018
1	Coma (Comas) 01/2018
1	Asthma (Bronchial Asthma) 01/2018
1	Hyperemia 10/2016
1	Hematologic Diseases (Blood Diseases) 07/2015
1	Bipolar Disorder (Manic Depressive Psychosis) 11/2013
1	Tuberculosis (Tuberculoses) 05/2013
1	Hematuria 05/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2013
1	Drug-Related Side Effects and Adverse Reactions 05/2013
1	Atrial Fibrillation 05/2013
1	Human Influenza (Influenza) 01/2012
1	Acute-Phase Reaction 02/2008
1	Cerebral Toxoplasmosis 03/2003
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2003

Drug/Important Bio-Agent (IBA)

21	ProcalcitoninIBA 01/2020 - 03/2008
19	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 01/2007
10	Biomarkers (Surrogate Marker)IBA 11/2021 - 10/2013
4	C-Reactive ProteinIBA 01/2020 - 01/2012
2	Pharmaceutical PreparationsIBA 01/2019 - 05/2013
2	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 05/2013
2	Interleukin-10 (Interleukin 10)IBA 10/2016 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 10/2016 - 02/2008
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 07/2013 - 09/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 01/2011
1	AntibodiesIBA 01/2022
1	SuspensionsIBA 01/2020
1	NeurotoxinsIBA 09/2019
1	Botulinum AntitoxinIBA 09/2019
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2019
1	Vancomycin FDA LinkGeneric 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 10/2016
1	LithostathineIBA 09/2015
1	Rifampin (Rifampicin)FDA LinkGeneric 05/2013
1	InterferonsIBA 01/2012
1	InterleukinsIBA 01/2012
1	Interleukin-8 (Interleukin 8)IBA 01/2011
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2011
1	Messenger RNA (mRNA)IBA 02/2008
1	AminoglycosidesIBA 01/2007
1	beta-LactamsIBA 01/2007

Therapy/Procedure

18	Therapeutics 11/2021 - 01/2007
3	Hematopoietic Stem Cell Transplantation 06/2021 - 07/2013
3	Duration of Therapy 01/2020 - 03/2008
3	Artificial Respiration (Mechanical Ventilation) 01/2020 - 07/2015
3	Length of Stay 01/2018 - 09/2012
2	Central Venous Catheters 07/2013 - 03/2009
1	Catheters 08/2021
1	Transplantation 06/2021
1	Resuscitation 04/2021
1	Noninvasive Ventilation 01/2020
1	Mechanical Ventilators (Ventilator) 01/2018
1	Critical Care (Surgical Intensive Care) 10/2013
1	Highly Active Antiretroviral Therapy (HAART) 03/2003